News from syneron medical ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 25, 2015, 07:00 ET
Syneron Medical Ltd logo

Study Published In May Issue Of Journal Of Dermatologic Surgery Demonstrates Significant Improvement In Face And Neck Treatment Results From New Profound Non-Surgical Procedure

Syneron Candela Treatment Boosts Growth of Elastin, Collagen And Hyaluronic Acid For Younger Skin Naturally Syneron Medical Ltd. (NASDAQ: ELOS),...

Jun 04, 2015, 16:05 ET
Syneron Medical Ltd logo

Syneron and Viora Announce Settlement Agreement of Business and Patent Litigations

 Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, and Viora Ltd. and Viora Inc., a...

May 13, 2015, 06:15 ET
Syneron Medical Ltd logo

Syneron Medical Reports Revenue of $63.4 Million for the First Quarter 2015

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period...

Apr 29, 2015, 09:25 ET
Syneron Medical Ltd logo

Syneron Medical to Report First Quarter 2015 Financial Results on May 13, 2015

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2015...

Apr 20, 2015, 09:00 ET
Syneron Medical Ltd logo

Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Treatment of Pigmented Lesions

 Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the...

Mar 25, 2015, 09:00 ET
Syneron Medical Ltd logo

Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website

 Syneron Medical Ltd. (Nasdaq: ELOS), a global market leader in the aesthetic medical device marketplace, today announced that its Annual...

Mar 20, 2015, 09:00 ET
Syneron Medical Ltd logo

Syneron Candela Presents Game-Changing Technologies During The American Academy of Dermatology Meeting

 Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, is proud to showcase revolutionary...

Mar 17, 2015, 09:00 ET
Syneron Medical Ltd logo

Syneron Candela Launches "Changing Lives" Program At AAD

 Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, today announced the introduction of...

Mar 05, 2015, 09:00 ET
Syneron Medical Ltd logo

Syneron Medical to Participate in the Barclays Global Healthcare Conference

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is...

Feb 18, 2015, 06:51 ET
Syneron Medical Ltd logo

Syneron Medical Reports Record Revenue of $74.1 Million for the Fourth Quarter 2014

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period...

Feb 18, 2015, 06:45 ET
A better way to a better body. New painless UltraShape ultrasound fat reduction

Syneron Candela's Ultrashape Is Challenging Exercise To Eliminate Stubborn Fat

 Syneron Medical Ltd. (NASDAQ: ELOS), a global leader in the aesthetic medical device marketplace, launched a national advertising campaign on...

Feb 12, 2015, 07:30 ET
Syneron Medical Ltd logo

Syneron Medical Appoints William Griffing to Newly Created Position of CEO of Syneron Candela North America

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has enhanced its North American leadership...

Feb 05, 2015, 09:25 ET
Syneron Medical Ltd logo

Syneron Medical to Report Fourth Quarter 2014 and Full Year 2014 Financial Results on February 18, 2015

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2014 and...

Feb 05, 2015, 09:20 ET
Syneron Medical Ltd logo

Syneron Medical to Participate in the 2015 Leerink Global Healthcare Conference

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Sarit Soccary Ben Yochanan, Vice...

Jan 15, 2015, 11:00 ET
UltraShape Wins NewBeauty Magazine Beauty Choice Awards For Best Body-Contouring Treatment

UltraShape Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment

UltraShape Is Recognized As A Breakthrough In Non-Invasive Abdominal Fat Reduction Thanks To Its Painless And Effective Ultrasound Technology...

Jan 12, 2015, 09:30 ET
Syneron Medical Ltd logo

Syneron Medical Strengthens Management Team with Addition of Chief Brand Officer

 Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced the expansion of its management team with the...

Jan 08, 2015, 07:00 ET
Syneron Medical Ltd logo

Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced preliminary fourth quarter 2014 revenue...

Dec 08, 2014, 09:31 ET
Syneron Medical Ltd logo

Syneron Candela Signs Agreement with American Medical Systems to Supply Holmium Laser for Urology

 Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the signing of a multi-year agreement with...

Dec 01, 2014, 08:00 ET
Syneron Medical Ltd logo

Syneron Medical Announces $20 Million Share Repurchase Program

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Board of Directors has authorized a...

Nov 17, 2014, 09:00 ET
Syneron Medical Ltd logo

Syneron Candela Expands Capabilities of UltraShape Non-Invasive Fat Destruction Platform, Receives FDA Clearance for the New U-Sculpt Transducer and Enhanced Ultrasound Power

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today the US Food and Drug Administration (FDA) clearance...